Skip to content

Roux-en-Y Hepaticojejunostomy for Hepatolithiasis With Sphincter of Oddi Laxity

The Role of Roux-en-Y Hepaticojejunostomy in Hepatolithiasis Patients With Sphincter of Oddi Laxity: an Open-label Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01459549
Enrollment
129
Registered
2011-10-25
Start date
2010-12-13
Completion date
2022-02-28
Last updated
2025-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatolithiasis, Sphincter of Oddi Dysfunction

Keywords

Hepatolithiasis, Sphincter of Oddi Dysfunction, Roux-en-Y hepaticojejunostomy, randomized controlled trial

Brief summary

Objective: Evaluate the role of Roux-en-Y hepaticojejunostomy (RYHJ) in hepatolithiasis patients with sphincter of Oddi laxity (SOL). Summary Background Data: Hepatolithiasis poses high risks of residual, recurrence, and re-intervention. SOL significantly impacts this condition. RYHJ has been recommended for hepatolithiasis concomitant SOL but without prospective evidence. Methods: This is an open-label randomized controlled trial recruiting patients with hepatolithiasis concurrent SOL. Patients were randomly assigned (1:1) to undergo RYHJ or not. The primary endpoint was stone occurrence, including residual and recurrence, within a three-year postoperative period. Secondary endpoints incorporated perioperative and long-term outcomes, like episodes of cholangitis and invasive re-interventions for stones and related complications. The analyses followed the intention-to-treat principle.

Interventions

All participants received routine perioperative care and followed the same surgical principles: removing affected liver segments, clearing stones, correcting strictures, and then restoring bile drainage. The primary indications for hepatectomy were unilobar or segmental diseases and the presence of the following lesions in the affected liver segment or lobe: 1) multiple stones with biliary strictures that cannot be cured via choledochoscopy, 2) atrophy, fibrosis, and multiple abscesses, and 3) suspicious neoplasia. Biliary exploration was routinely conducted to facilitate stone removal, rectify strictures, and assess the functionality of the Oddi sphincter. Following this, patients would be evaluated for eligibility and assigned accordingly. The sole distinction between the two arms was performing RYHJ or maintaining the common bile duct for bile drainage.

Sponsors

Zhejiang University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. aged between 18 and 80 years 2. diagnosed with SOL during operation 3. suitable for a radical surgery including RYHJ 4. hopeful to clear stones via operation or combined with subsequent choledochoscopy 5. provided written informed consent 6. willing to complete a 3-year follow-up An intraoperative diagnosis of SOL was established if the rhythmic contraction and relaxation of the sphincter of Oddi were not observed under choledochoscope and the flexible choledochoscope (CHF-P20, external diameter, 4.9 mm; Olympus, Tokyo, Japan) could navigate smoothly to the duodenum through the sphincter of Oddi without any pre-dilation interventions.

Exclusion criteria

1. with imaging evidences of tumor preoperatively 2. had congenital biliary malformations 3. had ever received biliary operation abandoning the Oddi sphincter, such as choledochoduodenostomy

Design outcomes

Primary

MeasureTime frameDescription
The incidence of stones, including residual and recurrent stones, within three years postoperatively.A three-year postoperative periodThe term stone occurrence pertained to the identification of any bile duct stones with the most reliable imaging modality available during the follow-up period. Stone residual described a patient in whom stones were detected during the initial follow-up examination, while stone recurrence referred to a patient who exhibited no stones at the first follow-up visit but subsequently presented with stones during later follow-up assessments.

Secondary

MeasureTime frameDescription
Major complicationsperioperationPostoperative complications were graded according to the Clavien-Dindo definition and those ranked Grade III or above were defined as major complications. Complications arising during unplanned readmission were also taken into account.
Episodes of cholangitis3-year follow-up periodEpisodes of cholangitis, regardless of definite or suspected one. The diagnosis of cholangitis were initially established according to the Tokyo 2007 guidelines and were subsequently revised following the Tokyo 2018 guidelines.
Invasive re-interventions for stones and related complications3-year follow-up periodThe term invasive re-interventions covered operation, percutaneous transhepatic cholangioscopy, and endoscopic retrograde cholangiopancreatography. The planned choledochoscopy following the initial surgical procedure was not lumped into invasive re-interventions.
Medical expensesperioperationMedical expenses covered all costs incurred throughout the course, including planned choledochoscopy and unplanned readmissions.
Unplanned readmission within 30 days postoperativelyperioperation
Postoperative hospital staysperioperationHospital stays arising during unplanned readmission were also taken into account

Other

MeasureTime frame
Cholangiocarcinoma arising3-year follow-up period

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026